Industry: Health care Region: France Transaction price: US$ 1 million Transaction method: equity investment
Project introduction:
A French professional in vitro diagnostic company is also a leading supplier of clinical protein electrophoresis equipment and reagents. Its products are mainly used for screening and monitoring of tumors (multiple myeloma), diabetes, hemoglobinopathy and other rare diseases. The company has made continuous progress in capillary electrophoresis technology, science and manufacturing capacity, thus providing higher standards for products and seeking new diagnostic solutions through new testing and automation equipment.
Product service introduction:
1. Instrument
From low capacity to high capacity, whether it is independent instruments, work unit configuration or direct integration into the laboratory automation track, it can provide suitable solutions for each laboratory.
Step 2 check
From multiple myeloma to metabolic disorders, hemoglobinopathy and genetic diseases, the product portfolio can meet clinical needs and improve laboratory efficiency and safety.
3. Software
A unique software is developed, through which users can interpret, manage, store and query the test results produced by the instrument. The software is easy to use and rich in functions. Its advanced network function can meet the complex laboratory needs, whether it is to manage the workload or customize the network application for remote access from any other site in the core laboratory or satellite locations in various towns.
Cooperation mode:
Looking for partners who need in vitro diagnostic technology solutions.